Prochlorperazine Edisylate NDC 72572-580

NDC codes

FDA NDC Directory

Product NDC (as listed)72572-580Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72572-0580Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72572-580-25	72572058025	25 VIAL in 1 CARTON (72572-580-25) / 2 mL in 1 VIAL (72572-580-01)Marketed from Nov 18, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Prochlorperazine Edisylate
Generic name (nonproprietary): prochlorperazine edisylate
Active ingredients: Prochlorperazine edisylate — 5 mg/mL
Dosage form: Injection
Route: Intramuscular, Intravenous
Labeler: Civica, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 089903
Marketing start: Nov 18, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Phenothiazines (Chemical structure)
Identifiers: Product ID 72572-580_7395a535-b3fc-4bb8-b2e1-d8c42b9a0509SPL ID 7395a535-b3fc-4bb8-b2e1-d8c42b9a0509SPL set ID e3e0c6c5-6b92-40e0-a926-29c64846be93RxCUI 314192UNII PG20W5VQZS
Pharmacologic class: Phenothiazine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N472572058025 followed by a unit qualifier and the quantity

Package 72572-0580-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 29, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE To control severe nausea and vomiting. For the treatment of schizophrenia. Prochlorperazine has not been shown effective in the management of behavioral complications in patients with mental retardation.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 089903

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 089903
Product	Strength	Form · route	Labeler	Product NDC
Prochlorperazine Edisylate	Prochlorperazine edisylate 5 mg/mL	InjectionIntramuscular, Intravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1558
Prochlorperazine Edisylate	Prochlorperazine edisylate 5 mg/mL	InjectionIntramuscular, Intravenous	Hikma Pharmaceuticals USA Inc.	0641-6135